Recent feedback from several regulatory agencies has demonstrated increased scrutiny of medical devices for aflatoxins and other chemical species in the Cohort of Concern (CoC). At Jordi Labs, we’re offering new ideas on how to best manage this scrutiny of medical device E&L.
The white paper and case study feature detailed information on:
- Aflatoxin detection
- Nitrosamines detection
- Azoxy compounds detection
The post Gain new perspective into the heightened scrutiny of medical device E&L appeared first on MassDevice.
from MassDevice http://ift.tt/2uS9xjP
Cap comentari:
Publica un comentari a l'entrada